NCT05424536

Brief Summary

Osteoporosis is a skeletal disease leading to bone fragility and increasing the risk of fractures and still remains a major public health problem worldwide. Therefore it is crucial to prevent severe fractures responsible for excess of mortality and considerable morbidity. Patient at risk of fractures are currently identified as having osteoporosis using Dual-energy X-ray Absorptiometry (DXA), assessing the areal or projected Bone Mineral Density (aBMD g.cm-2). In Chile, the hip fracture occurrence is very similar to the international incidence. Due to the demographic and epidemiological transition, the number of hip fracture for patient older than 50 year, is expected to severely increase from about 6.500 (2007) to 30.000 (2050) without adequate preventive and / or therapeutic measures. Even if DXA remains the current gold standard, it is limited by the difficulty to set a threshold in the BMD distribution for osteoporosis diagnosis. Moreover, some medical conditions (chronic kidney disease, diabetes) or drugs (glucocorticoids) are associated with an increase of fracture risk without a BMD decrease. Quantitative ultrasound (QUS) have the advantages of portability, low cost, absence of radiation and need for a radiographic technologist or designated room, and are sensitive to both elasticity and geometry of the medium explored by the waves. Among QUS techniques, axial transmission (AT) is a technique for which transducers are aligned along the bone axis. Measured ultrasonic guided waves, associated with an appropriate waveguide model have the potential to yield estimates of material and/or geometrical cortical properties. In vivo combined estimation of both cortical thickness and porosity has been proposed using bidirectional axial transmission (BDAT). BDAT measurement has been recently validated on ex vivo specimen (radius and tibia) and has been tested in a pilot clinical study, in which cortical porosity measured at the one-third distal radius has been found as discriminant of low trauma fractures as DXA. Cortical porosity is increasingly recognized as a major contributor to bone fragility. The hypothesis underlying this project are that (1) it is possible to obtain robust and accurate estimates of cortical thickness and porosity using an improved BDAT device and (2) these estimates are of clinical interest in the context of osteoporosis in elderly. Moreover, novel parameters obtained from automatic classification tools will be tested.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

July 18, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
Last Updated

January 16, 2026

Status Verified

January 1, 2023

Enrollment Period

6 months

First QC Date

June 14, 2022

Last Update Submit

January 14, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Cortical parameter measurement obtained by BDAT (Ultrasound)

    Cortical thickness (mm) at one-third distal radius and mid-tibia

    Inclusion time

  • Cortical parameter measurement obtained by BDAT (Ultrasound)

    Cortical porosity (%) at one-third distal radius and mid-tibia

    Inclusion time

  • Ultrasonic velocities measurement obtained by BDAT (Ultrasound)

    velocity (m.s-1) of the First Arriving Signal (VFAS) at one-third distal radius and mid-tibia

    Inclusion time

  • Ultrasonic velocities measurement obtained by BDAT (Ultrasound)

    velocity (m.s-1) of the A0 guided mode (A0) at one-third distal radius and mid-tibia

    Inclusion time

Secondary Outcomes (5)

  • Quality measurement parameter obtained by BDAT (Ultrasound)

    Inclusion time

  • femoral aBMD obtained by DXA

    Inclusion time

  • Body composition measurements obtained by DXA

    Inclusion time

  • 10-year probability of fracture provided by FRAX algotithm

    Inclusion time

  • 10-year probability of fracture provided by FRAX algotithm

    Inclusion time

Interventions

Measurement will be performed at radius and at tibia (ultra-distal and distal). For all the sites plus femoral neck, one measurement will be performed by DXA to get reference values of thickness and BMDs. For the distal positions and additional measurement will be performed by an innovative ultrasound device that estimates cortical thickness and porosity.

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The cohort will be: Women and men over 50 years old

You may qualify if:

  • \> 50 years old

You may not qualify if:

  • History of fracture
  • Corticoid treatment
  • Renal disease
  • Arthritis
  • BMI \< 15 and \> 30
  • Double femoral prosthesis
  • In case group/with fracture is added:
  • Recent femoral bone fragility fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Valparaíso

Valparaíso, Chile

Location

Related Links

MeSH Terms

Conditions

Osteoporotic Fractures

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and Injuries

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Jean-Gabriel Minonzio, Ph.D

    Universidad de Valparaiso

    PRINCIPAL INVESTIGATOR
  • José Luis Dinamarca, M.D.

    Universidad de Valparaiso

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2022

First Posted

June 21, 2022

Study Start

July 18, 2022

Primary Completion

January 24, 2023

Study Completion

January 31, 2024

Last Updated

January 16, 2026

Record last verified: 2023-01

Locations